Clinical Trial Results: Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab in combination with induction chemotherapy and chemoradiotherapy for non-small cell lung cancer with stages IIIA/IIIB; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Fundación GECP | Conditions: Lung Diseases, Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2026-07-22